prof. MUDr. Tomáš Büchler, Ph.D.
Total number of publications: 86
2023
-
2. ročník PROSTAFORUM 2023
Year: 2023, type: Conference
2020
-
Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients
CANCER MANAGEMENT AND RESEARCH, year: 2020, volume: 12, edition: 2020, DOI
-
Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib
Targeted Oncology, year: 2020, volume: 15, edition: 5, DOI
2019
-
Incidental Use of Beta-Blockers Is Associated with Outcome of Metastatic Colorectal Cancer Patients Treated with Bevacizumab-Based Therapy: A Single-Institution Retrospective Analysis of 514 Patients
Cancers, year: 2019, volume: 11, edition: 12, DOI
-
Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC
ADVANCES IN THERAPY, year: 2019, volume: 36, edition: 3, DOI
-
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 4, DOI
2017
-
Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
Biochemia Medica, year: 2017, volume: 27, edition: 2, DOI
-
Regorafenib in the Real-Life Clinical Practice: Data from the Czech Registry
Targeted Oncology, year: 2017, volume: 12, edition: 1, DOI
2016
-
Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients
Anticancer Research, year: 2016, volume: 36, edition: 9, DOI
2015
-
Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry
Anticancer Research, year: 2015, volume: 35, edition: 6